Contract with Customer, Liability, Noncurrent of Can-Fite BioPharma Ltd. from 31 Dec 2022 to 30 Jun 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.
Summary: Can-Fite BioPharma Ltd. quarterly Contract with Customer, Liability, Noncurrent in USD history and change rate from 31 Dec 2022 to 30 Jun 2025.
Can-Fite BioPharma Ltd. Contract with Customer, Liability, Noncurrent for the quarter ending 30 Jun 2025 was $1,383,000, a 3.6% decline year-over-year.
Source SEC data: View on sec.gov

Contract with Customer, Liability, Noncurrent, Quarterly (USD)

Contract with Customer, Liability, Noncurrent, YoY Quarterly Change (%)

Can-Fite BioPharma Ltd. Quarterly Contract with Customer, Liability, Noncurrent (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	$1,383,000	-$52,000	-3.6%	30 Jun 2025	6-K	28 Aug 2025	2025	Q2
Q4 2024	$1,581,000	-$132,000	-7.7%	31 Dec 2024	6-K	28 Aug 2025	2025	Q2
Q2 2024	$1,435,000			30 Jun 2024	6-K	29 Aug 2024	2024	Q2
Q4 2023	$1,713,000	-$582,000	-25%	31 Dec 2023	20-F	14 Apr 2025	2024	FY
Q4 2022	$2,295,000			31 Dec 2022	20-F	28 Mar 2024	2023	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.